← Back to Search

MOVIN Program for Early Mobility in Aging Adults

N/A

Recruiting

Led By Linsey M Steege, PhD

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

age 65 years or older

have an ambulation order

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 24 hours of hospital admission, within 8 hours of hospital discharge, 3 months post-discharge; up to 4 months total

Awards & highlights

Study Summary

This trial is testing a program to increase patient ambulation while hospitalized, to see if it improves functional outcomes for older adult patients by producing a change in nursing practice and culture of ambulation on inpatient units.

Who is the study for?

This trial is for older adults aged 65 or above who were living at home before hospital admission, can walk (with help if needed), and have a doctor's order to walk. They must be in the hospital's general medical unit and speak English. People with bed rest orders, severe cognitive issues like dementia, wheelchair users, amputees, or those receiving end-of-life care cannot join.Check my eligibility

What is being tested?

The MOVIN program aims to get older adult patients walking more during their hospital stay to improve their mobility and reduce healthcare needs after leaving the hospital. It changes how nurses encourage walking. All patients on certain units will experience MOVIN once it starts.See study design

What are the potential side effects?

Since MOVIN is about increasing patient movement rather than medication or surgery, side effects are not typical as with drug trials but may include fatigue or discomfort from increased activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 65 years old or older.

Select...

I am ordered to walk as part of my treatment.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 24 hours of hospital admission, within 8 hours of hospital discharge, 1 month post-discharge, 3 months post-discharge; 6 months post-discharge; up to 7 months total

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 24 hours of hospital admission, within 8 hours of hospital discharge, 1 month post-discharge, 3 months post-discharge; 6 months post-discharge; up to 7 months total

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 24 hours of hospital admission, within 8 hours of hospital discharge, 1 month post-discharge, 3 months post-discharge; 6 months post-discharge; up to 7 months total for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Life Space Assessment

Change in gait speed

Change in self-report on Activities of Daily Living (ADL)

Secondary outcome measures

Discharge Destination

Emergency Room Visits

Hospital Readmissions

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Post-interventionExperimental Treatment1 Intervention

160-200 older adult patients (age 65 or older) will be recruited on four units across two hospitals (two units per hospital) over 6 months after MOVIN has been implemented on the unit.

Group II: Pre-intervention/controlActive Control1 Intervention

160-200 older adult patients (age 65 or older) will be recruited on four units across two hospitals (two units per hospital) over 6 months prior to implementation of the unit-based MOVIN intervention.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor

1,187 Previous Clinical Trials

3,169,137 Total Patients Enrolled

Aurora Health CareOTHER

43 Previous Clinical Trials

15,825 Total Patients Enrolled

Agency for Healthcare Research and Quality (AHRQ)FED

399 Previous Clinical Trials

6,821,988 Total Patients Enrolled

Media Library

MOVIN Clinical Trial Eligibility Overview. Trial Name: NCT04479943 — N/A

Hospital Acquired Infection Research Study Groups: Pre-intervention/control, Post-intervention

Hospital Acquired Infection Clinical Trial 2023: MOVIN Highlights & Side Effects. Trial Name: NCT04479943 — N/A

MOVIN 2023 Treatment Timeline for Medical Study. Trial Name: NCT04479943 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there any availability for individuals to participate in this clinical trial?

"Affirmative. Clinicaltrials.gov reveals that this experiment is currently searching for recruits; it was first made public on March 10th 2021 and has since been modified as of October 31st 2022. The research necessitates 360 volunteers from 2 locations."

Answered by AI

What is the current sample size for this clinical experiment?

"Affirmative. Clinicaltrials.gov indicates that this trial, posted on March 10th 2021, is currently enrolling patients. 360 participants must be obtained across the two centres hosting the experiment."

Answered by AI

What primary objectives are being sought by this research endeavor?

"The primary outcome of this research project, which is to be evaluated within 24 hours post-hospital admission; 8 hours from hospital departure; a month after discharge; 3 months following medical release and up to 7 months in total, is the Change in Life Space Assessment. Secondary objectives include determining Discharge Destination via patient record reviews conducted by study staff nurses, Emergency Room Visits as reported both through medical records and self reports from patients themselves, as well as Hospital Readmissions again with dual sources for accuracy."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Improving Patient Walking During Hospitalization

2021. "Improving Patient Walking During Hospitalization". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04479943.